The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Sp898
SHOULD ELECTRONIC AND DYE-BASED CHROMOSCOPY REPLACE WHITE-LIGHT COLONOSCOPY AND RANDOM BIOPSIES FOR DYSPLASIA DETECTION IN PATIENTS WITH IBD: YES
Date
May 8, 2023
Explore related products in the following collection:
This annual session will provide DDW attendees the opportunity to hear opposing viewpoints from leading GI experts on the most challenging issues in clinical gastroenterology and hepatology, in a debate format. This 90-minute symposium will feature 3 debates among "heavyweight" faculty who will provide greater clarity as to how we can apply best evidence to clinical decision-making for these challenging topics. Debates focus on recently published AGA Clinical Practice Updates, which are evidence-based reviews and commentaries that address evolving areas of clinical practice and/or technology. These documents address topics of very high clinical importance, and are published in AGA's flagship journals Gastroenterology and CGH.
BACKGROUND: Cancer is a major cause of morbidity and mortality in persons with inflammatory bowel disease (IBD). We evaluated temporal trends and relative risks of intestinal and extra-intestinal cancers among persons with IBD and matched controls…
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
This annual session will provide DDW attendees the opportunity to hear opposing viewpoints from leading GI experts on the most challenging issues in clinical gastroenterology and hepatology, in a debate format…